Full Professor of Internal Medicine at the Department of Advanced Medical and Surgical Science, University of Campania “Luigi Vanvitelli”, Naples, Italy. Her research focuses on aging, particularly the molecular and metabolic mechanisms involved, including the relationship between aging, glucose metabolism, and cardiovascular diseases. She trained at the University of Bologna (Prof. Franceschi) and collaborated with the National Institute on Aging (Prof. Ferrucci) on the InCHIANTI Study. Over the last decade, she has investigated the genetic and epigenetic bases of longevity and their role in age-related metabolic and cardiovascular diseases. From 2013 to 2019, she participated in the MID-Frail Study with Spanish and UK partners, evaluating the effect of multimodal interventions in frail elderly patients with type 2 diabetes. Her main research topics include: a) molecular and metabolic mechanisms of aging and longevity; b) impact of lifestyle on frailty prevention; c) cardiometabolic risk in the elderly; d) glycemic variability and cardiovascular complications; e) relationship between glucose fluctuations and cognitive decline; f) role of genetic polymorphisms in age-related diseases; g) epigenetic changes associated with aging and cardiovascular conditions; h) role of SGLT2 in aortic stenosis and cardiac remodeling. Since 2024, she has been Director of the Residency Program in Geriatrics. She is the author of 179 publications (H-index 59; total IF > 500).
Award for Best Presentation for Scientific Contribution
SIGG_Società Italiana di Gerontologia e Geriatria
Blood pressure and plasma IGF-1 levels in healthy centenarians, presented at the 43rd SIGG Congress, Florence, November 12–15, 1998.
Best Presentation for Scientific Contribution
SIGG_Società Italiana di Gerontologia e Geriatria
Role of the Pro/Ala Polymorphism of the PPARγ Gene in the Determinism of Longevity, presented at the 49th SIGG Congress, Florence, November 7, 2004.
Highly Cited Research in Atherosclerosis Journal
Atherosclerosis Journal
in recognition of the contribution to the journal’s quality for the paper: Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors (published in 2013 and cited during 2014–2015 up to June 2016, according to Scopus data).